NCT02972866View on ClinicalTrials.gov

Clinical Study, Non Inferiority Between Noex® 32µg Versus Budecort Aqua® 32µg in Treatment of Alergic Rhinitis

PHASE3WithdrawnINTERVENTIONAL
0
Timeline

Start Date

June 30, 2016

Primary Completion Date

November 30, 2019

Study Completion Date

November 30, 2019

Conditions
Rhinitis, Allergic, Perennial
Interventions
DRUG

Budesonide

Suspention to nasal use, 2 atomization in each nostril during the morning and at night.

Trial Locations (1)

Unknown

Allergisa pesquisa dermato-cosmética ltda, Campinas

Sponsors
All Listed Sponsors
lead

Eurofarma Laboratorios S.A.

INDUSTRY